547 related articles for article (PubMed ID: 19299805)
1. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
Gormsen L; Finnerup NB; Almqvist PM; Jensen TS
Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
[TBL] [Abstract][Full Text] [Related]
2. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Blackburn-Munro G; Bomholt SF; Erichsen HK
Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.
Tremont-Lukats IW; Hutson PR; Backonja MM
Clin J Pain; 2006; 22(3):266-71. PubMed ID: 16514327
[TBL] [Abstract][Full Text] [Related]
5. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
7. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.
Kvarnström A; Karlsten R; Quiding H; Gordh T
Acta Anaesthesiol Scand; 2004 Apr; 48(4):498-506. PubMed ID: 15025615
[TBL] [Abstract][Full Text] [Related]
8. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
Yucel A; Ozyalcin S; Koknel Talu G; Kiziltan E; Yucel B; Andersen OK; Arendt-Nielsen L; Disci R
Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
[TBL] [Abstract][Full Text] [Related]
9. The analgesic effect of a metered-dose 8% lidocaine pump spray in posttraumatic peripheral neuropathy: a pilot study.
Kanai A; Segawa Y; Okamoto T; Koto M; Okamoto H
Anesth Analg; 2009 Mar; 108(3):987-91. PubMed ID: 19224814
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
11. Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models--two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers.
Gustorff B; Hauer D; Thaler J; Seis A; Draxler J
Expert Opin Pharmacother; 2011 Dec; 12(18):2781-90. PubMed ID: 21774743
[TBL] [Abstract][Full Text] [Related]
12. Cizolirtine citrate (E-4018) in the treatment of chronic neuropathic pain.
Shembalkar P; Täubel J; Abadias M; Arezina R; Hammond K; Anand P
Curr Med Res Opin; 2001; 17(4):262-6. PubMed ID: 11922399
[TBL] [Abstract][Full Text] [Related]
13. Dental impaction pain model as a potential tool to evaluate drugs with efficacy in neuropathic pain.
Malmstrom K; Kotey P; McGratty M; Ramakrishnan R; Gottesdiener K; Reicin A; Wagner JA
J Clin Pharmacol; 2006 Aug; 46(8):917-24. PubMed ID: 16855076
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
[TBL] [Abstract][Full Text] [Related]
15. Systemic adenosine infusion reduces the area of tactile allodynia in neuropathic pain following peripheral nerve injury: a multi-centre, placebo-controlled study.
Sjölund KF; Belfrage M; Karlsten R; Segerdahl M; Arnér S; Gordh T; Solevi A
Eur J Pain; 2001; 5(2):199-207. PubMed ID: 11465985
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant use of intravenous lidocaine for procedural burn pain relief: a randomized double-blind, placebo-controlled, cross-over trial.
Wasiak J; Spinks A; Costello V; Ferraro F; Paul E; Konstantatos A; Cleland H
Burns; 2011 Sep; 37(6):951-7. PubMed ID: 21497022
[TBL] [Abstract][Full Text] [Related]
20. Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.
Pitkänen A; Mathiesen C; Rønn LC; Møller A; Nissinen J
Epilepsy Res; 2007 Apr; 74(1):45-54. PubMed ID: 17289347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
